Phreesia (NYSE:PHR) Posts Earnings Results, Beats Estimates By $0.06 EPS

Phreesia (NYSE:PHR - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06, RTT News reports. The firm had revenue of $115.94 million for the quarter, compared to the consensus estimate of $115.00 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm's quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the business posted ($0.05) EPS. Phreesia updated its FY 2026 guidance to EPS.

Phreesia Price Performance

Shares of PHR traded up $0.12 during mid-day trading on Friday, hitting $24.55. The company's stock had a trading volume of 672,417 shares, compared to its average volume of 446,701. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a 50-day simple moving average of $24.87 and a 200 day simple moving average of $25.24. The firm has a market capitalization of $1.46 billion, a P/E ratio of -16.70 and a beta of 0.74. Phreesia has a 1-year low of $17.07 and a 1-year high of $30.53.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Citigroup restated a "buy" rating on shares of Phreesia in a research note on Wednesday. Wall Street Zen downgraded Phreesia from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Canaccord Genuity Group lowered their target price on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a research note on Thursday. Truist Financial lifted their target price on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $29.00 target price on shares of Phreesia in a research note on Thursday, March 13th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $31.33.

Insider Activity

In related news, insider Yvonne Hui sold 1,878 shares of Phreesia stock in a transaction on Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total transaction of $44,790.30. Following the completion of the transaction, the insider now directly owns 28,449 shares of the company's stock, valued at approximately $678,508.65. The trade was a 6.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 3,496 shares of Phreesia stock in a transaction on Monday, March 17th. The stock was sold at an average price of $25.32, for a total value of $88,518.72. Following the transaction, the general counsel now directly owns 139,134 shares of the company's stock, valued at approximately $3,522,872.88. This represents a 2.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 42,474 shares of company stock valued at $1,023,208 in the last three months. 5.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Phreesia

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Caxton Associates LLP acquired a new position in Phreesia during the first quarter worth $316,000. Goldman Sachs Group Inc. raised its holdings in shares of Phreesia by 0.4% in the first quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company's stock worth $15,336,000 after acquiring an additional 2,402 shares during the last quarter. NewEdge Advisors LLC raised its holdings in shares of Phreesia by 262.7% in the first quarter. NewEdge Advisors LLC now owns 15,437 shares of the company's stock worth $395,000 after acquiring an additional 11,181 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Phreesia by 3.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company's stock worth $1,599,000 after acquiring an additional 2,158 shares during the last quarter. Finally, AQR Capital Management LLC raised its holdings in shares of Phreesia by 471.2% in the first quarter. AQR Capital Management LLC now owns 160,032 shares of the company's stock worth $4,090,000 after acquiring an additional 132,015 shares during the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.